Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy. - Santacana Juncosa E; Rodríguez-Alonso L; Padullés Zamora A; Guardiola J; Rodríguez-Moranta F; Serra Nilsson K; Bas Minguet J; Morandeira Rego F; Colom Codina H; Padullés Zamora N (British journal of clinical pharmacology, 2021)